Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

1. Melatonin for Insomnia: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines

Melatonin for Insomnia: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines Melatonin for Insomnia: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines | CADTH.ca Find the information you need Melatonin for Insomnia: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines Melatonin for Insomnia: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines Last updated: February 22, 2019 Project Number: RC1073-000 Product Line: Research (...) Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of melatonin for the treatment of insomnia in adults? What is the cost-effectiveness of melatonin for the treatment of insomnia in adults? What are the evidence-based guidelines regarding the use of melatonin for the treatment of insomnia in adults? Key Message Evidence of limited quality from four systematic reviews and two randomized controlled trials suggested modest favourable

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

2. Melatonin (Slenyto) - Treatment of insomnia in children and adolescents aged 2 to 18 years with autism spectrum disorder and / or Smith-Magenis syndrome

Melatonin (Slenyto) - Treatment of insomnia in children and adolescents aged 2 to 18 years with autism spectrum disorder and / or Smith-Magenis syndrome 1 Published 9 September 2019 1 SMC2168 melatonin 1mg and 5mg prolonged-release tablets (Slenyto®) Flynn Pharma Ltd 9 August 2019 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in NHSScotland. The advice is summarised (...) as follows: ADVICE: following a full submission melatonin prolonged-release (Slenyto ® ) is not recommended for use within NHSScotland. Indication under review: Treatment of insomnia in children and adolescents aged 2 to 18 years with autism spectrum disorder and / or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient. Melatonin prolonged-release (Slenyto ® ), compared with placebo, increased total sleep time and sleep onset latency in children aged 2 to 17.5 years with sleep

2019 Scottish Medicines Consortium

3. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update Original Paper British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders SJ Wilson 1 , DJ Nutt 2 , C Alford 3 , SV Argyropoulos 4 , DS Baldwin 5 , AN Bateson 6 , TC Britton 7 , C Crowe 8 , D-J Dijk 9 , CA Espie 10 , P Gringras 11 , G Hajak 12 , C (...) , whichrepresents the views of all participants although the authors take final responsibility for the document. Keywords Sleep, insomnia, parasomnia, circadian rhythm disorder, consensus, treatment Introduction Sleepdisordersarecommoninthegeneralpopulationandeven more so in clinical practice, yet are relatively poorly under- stood by doctors and other health care practitioners. These BritishAssociationforPsychopharmacology(BAP)guidelines aredesignedtoaddressthisproblembyprovidinganaccessible yetup

2019 British Association for Psychopharmacology

4. Insomnia

Insomnia © 2019 Kaiser Foundation Health Plan of Washington. All rights reserved. 1 Insomnia Guideline Guideline Summary 2 Background 2 Assessment and Diagnosis 3 Monitoring 4 Treatment Foundations Normal sleep pattern changes in the elderly 5 Step-wise approach to insomnia treatment 5 Behavioral treatment 6 Complementary/alternative therapy 7 Adjunctive pharmacologic treatment if no response to behavioral treatment 8 Recommendations for Special Populations 10 Follow-up 10 Referral 10 Evidence (...) consultation with Women’s Health. Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep for a month or longer. Individuals with insomnia may have one or more of the following symptoms: • Difficulty falling asleep • Waking up often during the night and having trouble going back to sleep • Waking up too early in the morning • Feeling tired upon waking Acute insomnia is insomnia lasting less than 6 weeks. Chronic insomnia is insomnia occurring at least 3 nights a week for more

2019 Kaiser Permanente Clinical Guidelines

5. Belsomra (Suvorexant) - for the treatment of insomnia

Belsomra (Suvorexant) - for the treatment of insomnia Search Page - Drug and Health Product Register Language selection Search and menus Search Search website Search Topics menu You are here: Summary Basis of Decision - - Health Canada Expand all Summary Basis of Decision (SBD) for Contact: Summary Basis of Decision (SBD) documents provide information related to the original authorization of a product. The for is located below. Recent Activity for SBDs written for approved after September 1

2019 Health Canada - Drug and Health Product Register

6. Proof of Concept for an Adaptive Treatment Strategy to Prevent Failures in Internet-Delivered CBT: A Single-Blind Randomized Clinical Trial With Insomnia Patients

Proof of Concept for an Adaptive Treatment Strategy to Prevent Failures in Internet-Delivered CBT: A Single-Blind Randomized Clinical Trial With Insomnia Patients This study aimed to demonstrate proof of concept for an adaptive treatment strategy in Internet-delivered cognitive-behavioral therapy (ICBT), where risk of treatment failure is assessed early in treatment and treatment for at-risk patients is adapted to prevent treatment failure.A semiautomated algorithm assessed risk of treatment (...) failure early in treatment in 251 patients undergoing ICBT for insomnia with therapist guidance. At-risk patients were randomly assigned to continue standard ICBT or to receive adapted ICBT. The primary outcome was self-rated insomnia symptoms using the Insomnia Severity Index in a linear mixed-effects model. The main secondary outcome was treatment failure (having neither responded nor remitted at the posttreatment assessment).A total of 102 patients were classified as at risk and randomly assigned

2019 EvidenceUpdates

7. Combined electroacupuncture and auricular acupuncture for primary insomnia: a randomised controlled trial of dose-response effect. (PubMed)

Combined electroacupuncture and auricular acupuncture for primary insomnia: a randomised controlled trial of dose-response effect. 30674705 2019 01 24 1024-2708 25 Suppl 2 2019 Feb Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Combined electroacupuncture and auricular acupuncture for primary insomnia: a randomised controlled trial of dose-response effect. 28-33 Chung K F KF Department of Psychiatry, The University of Hong Kong. Yeung W F WF School of Chinese Medicine

2019 Hong Kong medical journal = Xianggang yi xue za zhi

8. Effect of Traditional East Asian Medicinal herbal tea (HT002) on insomnia: a randomized controlled pilot study. (Full text)

Effect of Traditional East Asian Medicinal herbal tea (HT002) on insomnia: a randomized controlled pilot study. Complementary and alternative medicine treatment for insomnia has been sought due to the possible adverse effects of conventional pharmacotherapies. We performed a preliminary evaluation of the feasibility of using, and of the effect of a herbal tea (HT002), based on Traditional East Asian Medicine, in mild-to-moderate insomnia.Patients (n = 40) with mild-to-moderate insomnia were (...) randomized to the HT002 (n = 20) or waitlist (n = 20) groups. The HT002 group consumed HT002 twice daily for 4 weeks. Outcomes were assessed using the Insomnia Severity Scale (ISI), Pittsburgh Sleep Quality Index (PSQI), and 12-item Short Form Health Survey (SF-12) at baseline and after 4 and 8 weeks.The ISI score differences from baseline at weeks 4 and 8 were significantly greater in the HT002 than that in the waitlist group (week 4: -4.0 ± 0.8 vs. -0.4 ± 0.8, p < 0.05; week 8: -4.8 ± 0.7 vs. -0.9

2019 Integrative medicine research PubMed

9. Zao ren an shen for insomnia: a systematic review with meta-analysis

Zao ren an shen for insomnia: a systematic review with meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

10. The effectiveness and safety of Chinese herbal medicine xiaoyao formula for the treatment of insomnia: protocol for a systematic review and meta-analysis

The effectiveness and safety of Chinese herbal medicine xiaoyao formula for the treatment of insomnia: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

11. A network meta-analysis protocol of non-pharmaceutical treatments for insomnia

A network meta-analysis protocol of non-pharmaceutical treatments for insomnia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

12. Acupuncture for insomnia associated with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials

Acupuncture for insomnia associated with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

13. Prevalence, predictors and treatment of insomnia in palliative care: a systematic review

Prevalence, predictors and treatment of insomnia in palliative care: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

14. Efficacy and safety of Chaihu-longgu-muli decoction (Chinese herbal medicine) for primary insomnia: a systematic review of randomized controlled trials

Efficacy and safety of Chaihu-longgu-muli decoction (Chinese herbal medicine) for primary insomnia: a systematic review of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

15. Efficacy and safety of acupuncture for insomnia: a systematic review and meta-analysis

Efficacy and safety of acupuncture for insomnia: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

16. The impact of insomnia on the prognosis of obstructive sleep apnea: a systemic review and meta-analysis

The impact of insomnia on the prognosis of obstructive sleep apnea: a systemic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

17. Efficacy and safety of Wuling Capsule for insomnia: a systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of Wuling Capsule for insomnia: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

18. Effectiveness and safety of warm needle acupuncture on insomnia in climacteric women: protocol for a systematic review and meta-analysis

Effectiveness and safety of warm needle acupuncture on insomnia in climacteric women: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

19. Mechanisms of change in cognitive behaviour therapy for insomnia: a systematic review and meta-analysis of studies of mediators

Mechanisms of change in cognitive behaviour therapy for insomnia: a systematic review and meta-analysis of studies of mediators Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

20. Cognitive behavior therapy for insomnia in cancer survivors: a systematic review of randomized controlled trials

Cognitive behavior therapy for insomnia in cancer survivors: a systematic review of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO